![]()
Shares of BillionToOne, Inc. (“BillionToOne”) fell over 6% on November 18, 2026, after Fuzzy Panda Research published a report alleging that the company is the subject of an undisclosed state Medicaid fraud investigation and has engaged in improper billing practices. Gibbs Mura is investigating a potential BillionToOne (NASDAQ: BLLN) Securities Class Action Lawsuit concerning whether BillionToOne has violated federal securities laws by providing false or misleading statements to investors.
YOU MAY BE ABLE TO RECOVER YOUR LOSSES. VISIT OUR BILLIONTOONE CLASS ACTION LAWSUIT INVESTIGATION WEBPAGE OR CALL US AT (888) 410-2925 TO LEARN MORE.
What is the BillionToOne Legal Investigation About?
BillionToOne is a California-based molecular diagnostics company that sells blood tests for prenatal screening and cancer care. On November 18, 2026, Fuzzy Panda Research published a report alleging that Tennessee Medicaid’s Office of Program Integrity referred the company to state investigators for suspected fraud in 2024, after receiving eleven tips. According to the Fuzzy Panda report, Tennessee investigators found that “a credible allegation of fraud has been established,” due to a pattern of inappropriate billing and violations of state and federal False Claims Acts. Fuzzy Panda claims BillionToOne has never disclosed this investigation to investors.
The report further alleges that BillionToOne is billing for carrier testing at a “suspiciously high rate,” and may be illegally submitting claims to Medicaid for medically unnecessary testing.
Following this news, shares of BillionToOne dropped over 6% on November 18, 2026, causing harm to investors.
What Should BillionToOne Investors Do?
If you purchased BillionToOne (NASDAQ: BLLN) stock and lost money, visit our BillionToOne securities class action investigation page or contact our firm’s securities fraud attorneys at (888) 410-2925 to get more information about how you may be able to recover your losses. All calls are free and confidential.
About Gibbs Mura
Gibbs Mura represents investors nationwide in securities litigation and has more than two decades of experience prosecuting fraud. The firm has recovered billions of dollars for its clients against some of the world’s largest corporations, and our attorneys have received numerous honors for their work, including “Best Lawyers in America,” “Top Plaintiff Lawyers in California,” “California Lawyer Attorney of the Year,” “Class Action Practice Group of the Year,” “Consumer Protection MVP,” and “Top Women Lawyers in California.”
This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261118010996/en/
Media gallery